10x Genomics, Inc.

TXG

$61.26

-3.10%

2026-09-04 09:48:19 EDT-$1.96

Healthcare

Biotechnology

NASDAQ

Active Trading

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent ...

Financial Highlights of TXG

Profitability trend

Latest / TTM · 6 periods

Gross Margin

70.0%

Net Margin

-12.2%

P/E Ratio

-107.15x

n/a

Debt / Equity

0.10

n/a

Current Ratio

5.69

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

70.0%

Net Margin

-12.2%

P/E Ratio

-107.15x

Debt / Equity

0.10

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	84.9%	76.7%	66.2%	67.9%	69.1%	—
Operating MarginOperating income as a percentage of revenue.	-10.8%	-32.5%	-42.9%	-31.9%	-17.2%	—
Net MarginNet income as a percentage of revenue.	-11.9%	-32.1%	-41.2%	-29.9%	-6.8%	—
EBITDA MarginEBITDA divided by revenue.	-5.0%	-24.9%	-33.2%	-21.9%	0.6%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-11.0%	-31.4%	-40.2%	-29.1%	-6.2%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	6.77	4.85	4.69	4.97	4.46	—
Quick RatioLiquid assets divided by current liabilities.	6.23	4.23	4.11	4.26	4.09	—
Cash RatioCash and equivalents divided by current liabilities.	5.32	1.68	2.83	2.92	3.09	—
Debt / AssetsDebt as a share of total assets.	8.0%	9.2%	9.9%	9.0%	15.1%	—
Debt / EquityDebt compared with shareholder equity.	0.10	0.12	0.13	0.12	0.20	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	5.75x	4.96x	5.39x	6.95x	7.79x	—
Inventory TurnoverHow often inventory is sold in a year.	1.24x	1.47x	2.84x	2.36x	3.53x	—
Payables TurnoverHow often payables are paid in a year.	4.27x	5.57x	13.31x	15.21x	15.62x	—
Asset TurnoverRevenue generated per dollar of assets.	0.48x	0.50x	0.64x	0.66x	0.62x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.76x	0.90x	1.27x	1.31x	1.29x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-281.06x	-24.96x	-25.67x	-9.45x	-46.60x	—
P/B RatioPrice paid for each dollar of book value.	20.11x	5.15x	8.85x	2.44x	2.56x	—
P/S RatioPrice paid for each dollar of sales.	33.51x	8.03x	10.60x	2.83x	3.17x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-134.02x	-25.10x	-101.30x	-301.92x	15.64x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer